5265 articles
Gigi Sorenson, R.N., GlobalMed's Chief Clinical Officer and Vice President of Operations, discusses the benefits of telemedicine in pediatric care.
Scot Ebbinghaus from Merck Research Laboratories discusses Merck's KEYTRUDA with Inlyta as first-line treatment for advanced renal cell carcinoma.
Suela Sulo, a study author & health outcomes researcher at Abbott talks about the first-of-its-kind study published in the Journal of Parenteral and Ent...
Darius Francescatti, a breast surgeon with Rush University Medical Center, discusses the latest technological advances designed to enhance the effective...
Shore discusses the FDA approval of NUBEQA® (darolutamide) for the treatment of non-metastatic castration-resistant prostate cancer.
Jim Omel discusses his participation in the INSIGHT MM & the benefits of real-world evidence with patients participating in trials in multiple myeloma.
Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the lar...
Shawn Singh, CEO of VistaGen Therapeutics discusses their pipeline which includes nasal sprays that work like spritzers to the brain, for instance, PH10...
Aswini Misro talks about building a free artificial intelligence application to reduce monopoly in healthcare and to educate the patient.
Jeff Leighton, a professional pharmacologist, discusses the science behind the newly launched REVIVE, a non-caffeinated energy supplement.